Mandate

Vinge advises Ellevio on acquisition of Elektra Nät and Helsinge Elhandel

Vinge has acted for Ellevio in connection with its acquisition of the shares in Elektra Nät AB, an electricity distribution network operator, and AB Helsinge Elhandel, an energy supplier, from AB Edsbyns Elverk (publ).

The sale is conditional on e.g. approval from the extraordinary shareholders meeting of Edsbyns Elverk and closing is expected to take place on 4 January 2021. In parallel with Ellevio’s acquisition, Edsbyns Elverk has also recommended the extraordinary shareholders meeting to approve a sale of the group’s hydro power business to Fröslida Kraft KB as well as a sale of the electricity installation company Elektra i Hälsingland AB to Kraftkonsult i Skandinavien AB.

Ellevio is one of Sweden’s biggest distribution network operators with ca. 960,000 customers and 500 employees. Ellevio is owned by Tredje AP fonden, Folksam, Första AP fonden and OMERS Infrastructure.

Vinge’s team comprised partner in charge Peter Sundgren (Energy/M&A) and associates Michaela Cronemyr (M&A) and Oliviva Belding (M&A), partner David Andersson (Capital markets and Public M&A) and associate Ludvig Frithiof (Capital markets and Public M&A), partner Johan Cederblad (Environmental law/Real Estate) and associates Kristoffer Larson (Real Estate), Olof Löfvenberg (Environmental law/Real Estate), Karl-Hugo Engdahl (Corporate Commercial), Sara Strandberg (Employment) and Lisa Ullman (Employment).

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025